» Articles » PMID: 23960877

Intravitreal Bevacizumab for Posterior Capsule Neovascularization

Overview
Specialty Ophthalmology
Date 2013 Aug 21
PMID 23960877
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

We report a case of rapid regression of extensive posterior capsule neovascularization in a 67-year-old diabetic male patient, who developed posterior capsule opacity with neovascularization one year post cataract surgery, after a single injection of intravitreal bevacizumab (Avastin) followed by neodymium:YAG capsulotomy. Rapid regression of the posterior capsule neovascularization, and visual improvement was observed 9 days after the intervention. Posterior capsulotomy was performed successfully without bleeding. Prior to posterior capsulotomy, intravitreal bevacizumab can result in rapid and dramatic regression of posterior capsule neovascularization.

Citing Articles

Posterior lens capsule neovascularization treated with anti-VEGF complicated by phacogenic uveitis.

Tai F, Mandelcorn E, Somani S Am J Ophthalmol Case Rep. 2020; 20:100943.

PMID: 33204896 PMC: 7652777. DOI: 10.1016/j.ajoc.2020.100943.

References
1.
Bashshur Z, Bazarbachi A, Schakal A, Haddad Z, El Haibi C, Noureddin B . Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol. 2006; 142(1):1-9. DOI: 10.1016/j.ajo.2006.02.037. View

2.
Dowler J, Mehta J, Landers A, Hamilton A . Idiopathic anterior hyaloid vessels. Br J Ophthalmol. 2003; 87(3):365-6. PMC: 1771567. DOI: 10.1136/bjo.87.3.365. View

3.
Avery R, Pieramici D, Rabena M, Castellarin A, Nasir M, Giust M . Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology. 2006; 113(3):363-372.e5. DOI: 10.1016/j.ophtha.2005.11.019. View

4.
Lewis H, Abrams G, Williams G . Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987; 104(6):607-13. DOI: 10.1016/0002-9394(87)90173-5. View

5.
Avery R . Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina. 2006; 26(3):352-4. DOI: 10.1097/00006982-200603000-00016. View